CoreCap Advisors
SOPH icon

CoreCap Advisors’s SOPHiA GENETICS SOPH Stock Holding History

CoreCap Advisors’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-490
Closed -$2.83K – 3333
2026
Q2 		$2.83K Buy
+490
New +$2.49K ﹤0.01% 2447

Other funds holding SOPH

Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Sowell Financial Services
Sowell Financial Services North Little Rock, Arkansas $3.12B AUM 22.73% 1-Year Est. Return
Bank Pictet & Cie (Europe)
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.31B AUM 25.55% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $211M AUM 58.81% 1-Year Est. Return
Green Alpha Advisors
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Toth Financial Advisory
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

CoreCap Advisors's SOPH Position: Q3 2026 in Review

CoreCap Advisors sold out of SOPHiA GENETICS (SOPH) in Q3 2026, closing a stake of 490 shares — an estimated $2.83K sold.

CoreCap Advisors first reported a position in SOPH in Q2 2026 and held it in 1 quarter. The position peaked at $2.83K in Q2 2026. 10 funds tracked by Wall St. Rank hold SOPH as of Q3 2026.

  • CoreCap Advisors reported no remaining SOPHiA GENETICS position as of Q3 2026 after selling out during the quarter.
  • CoreCap Advisors sold 490 SOPHiA GENETICS shares in Q3 2026, an estimated $2.83K.
  • CoreCap Advisors first reported a position in SOPHiA GENETICS in Q2 2026 and held it in 1 quarter.
  • CoreCap Advisors's SOPHiA GENETICS position peaked at $2.83K in Q2 2026.
  • 10 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.